[ad_1]
A nursing assistant who was paralyzed after receiving an injection of AstraZeneca’s Covid-19 vaccine will receive compensation from the South Korean state after being recognized as a victim of a work-related accident.
The health worker, whose name has not been released, was vaccinated against Covid-19 on March 12. She then suffered from double vision and paralysis – and was diagnosed with a rare autoimmune disease known as acute encephalomyelitis. Compensation & Welfare Service said in a statement Friday.
After examining the file, the agency found that there was “Reasonable causal relationship between side effects and vaccination”. He also pointed out that the nurse had no underlying health issues that could complicate his condition.
Also on rt.com
Norway to pay compensation for AstraZeneca side effects as Pfizer & Moderna patients watch and wait
The woman had received the vaccine – jointly developed by Anglo-Swedish pharmaceutical giant AstraZeneca and the University of Oxford – during her working hours for “Comply with the recommendations of his employer”, the statement read. “She would have been in a difficult situation at her workplace if she had not been vaccinated”, he added.
For these reasons, the nurse was recognized as the victim of a “work accident” in the first such case in South Korea. The decision entitles him to compensation and government benefits under the Workers’ Compensation Insurance Act.
She will be compensated for missed hours of work, expenses and disabilities also to be covered by the state, the agency said.
Also on rt.com
Pyongyang rejects AstraZeneca Covid-19 vaccine due to side effects – South Korean think tank
Contacted by Reuters, AstraZeneca declined to comment on the case, saying patient safety is the company’s top priority and reaffirming that the jab offers “A high level of protection against all the severities of Covid-19 and the worrisome variants”.
Reports of severe blood clots and low platelet counts associated with the AstraZeneca vaccine – currently distributed under the brands Covishield and Vaxzevria – led a number of countries to restrict its use in young people earlier this year. Some countries, such as Denmark and Norway, have gone so far as to suspend the jab altogether for fear of side effects.
Do you like this story? Share it with a friend!
[ad_2]
Source link